Department of Health and Human Services, through National Institutes of Health, awarded Aventusoft L.l.c of Boca Raton, FL $500,000 under the SBIR program (Phase II), with work starting 2026-09-01 and running to 2027-08-31. It is one of 3 SBIR and STTR awards Aventusoft L.l.c received in the last two years, $1,349,855 in all. Each figure links to the federal record.
The award
| Recipient | Aventusoft L.l.c (Boca Raton, FL) |
|---|---|
| Awarding agency | Department of Health and Human Services |
| Awarding office | National Institutes of Health |
| Phase | Phase II |
| Amount obligated | $500,000 |
| Period of performance starts | 2026-09-01 |
| Period of performance ends | 2027-08-31 |
| Award number | SB1HL184385 (grant, CFDA 93.837) |
| Assistance listing | 93.837, Cardiovascular Diseases Research |
| Place of performance | Boca Raton, Palm Beach County, FL |
| Signed | 2026-08-17 |
| Recipient registry id (UEI) | LX1DCB3LCT87 |
Want the whole picture on Aventusoft L.l.c?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Aventusoft L.l.c: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Aventusoft L.l.c covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
22 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
What it is for
Commercialization readiness pilot program support for: Hemolink - 7. Project summary/abstract cardiovascular disease remains the leading cause of mortality for both men and women in the united states, accounting for appr
Funding actions on this award
| Date | Action | Modification | Amount |
|---|---|---|---|
| 2026-08-17 | New | 000 | $500,000 |
Commercialization readiness pilot program support for: Hemolink - 7. Project summary/abstract cardiovascular disease remains the leading cause of mortality for both men and women in the united states, accounting for approximately 33.6% of all deaths. The economic burden is equally significant, with total annual costs estimated at $363 billion, underscoring the urgent need for innovative, cost-effective approaches to disease management. Left ventricular end-diastolic pressure (lvedp) serves as a critical hemodynamic parameter, reflecting ventricular compliance as well as intravascular volume and pressure. Clinically, lvedp correlates with both acute and chronic conditions impacting cardiac function, making IT a valuable biomarker for guiding diagnosis and therapeutic management. Personalized, home-based monitoring of lvedp has the potential to transform cardiac care by enabling timely clinical decision-making and reducing hospitalizations. Through prior support from a parent SBIR Phase II award (1R44HL167296), we successfully developed and validated a novel non-invasive algorithm for lvedp estimation, yielding absolute, accurate, and actionable hemodynamic data suitable for remote monitoring. Our development efforts have been bolstered by strong collaborations with clinical partners, demonstrating the feasibility and clinical utility of our approach. However, a critical funding ...
From the federal award record.
Other SBIR and STTR awards to Aventusoft L.l.c
| Starts | Agency | Program | Amount | Project |
|---|---|---|---|---|
| 2025-09-05 | Department of Health and Human Services | SBIR Phase I | $349,855 | An innovative ai-powered wearable physiological sensor system for real-time pain monitorin (record) |
| 2025-07-15 | Department of Health and Human Services | SBIR Phase II | $500,000 | Commercialization readiness pilot program support for: Hats-off - 7. Project summary/abstr (record) |
Every other federal award to Aventusoft L.l.c on record
The federal register lists 19 other awards to the same registry id (UEI LX1DCB3LCT87), $15,816,341 in all, from 5 agencies.
| Starts | Agency | Amount | Award |
|---|---|---|---|
| 2026-09-18 | National Institutes of Health | $500,000 | A smart remote monitoring system for cardiometabolic management in patients with alzheimer's and related demen (R43AG099700) |
| 2023-04-01 | National Institutes of Health | $2,125,155 | A mobile health framework for left ventricular end diastolic pressure diagnostics and monitoring. - project su (R44HL167296) |
| 2021-09-20 | National Institutes of Health | $225,000 | Innovative, non-invasive, battery-less, disposable cardiac biosensor for hemodynamic monitoring - 7. Project s (R43EB029884) |
| 2020-04-15 | National Institutes of Health | $3,664,582 | A novel non-invasive device for screening and optimized management to improve heart failure outcomes in patien (R44HL149561) |
| 2019-06-01 | National Institutes of Health | $4,525,747 | Non-invasive cloud connected device for hemodynamic-guided therapy toimprove outcomes for heart failure patien (R44HL145941) |
| 2017-09-25 | Department of the Army | $149,986 | SBIR Phase I tasking (W81XWH17C0119) |
| 2017-06-06 | National Institutes of Health | $225,000 | Innovation for the earlydetection, diagnosis, and quantification of diabetic cardiomyopathy. (R43DK113890) |
| 2015-04-15 | National Science Foundation | $838,000 | SBIR Phase II: Multi-dimensional cardiogram device for monitoring of heart diseases (1456401) |
| 2015-04-01 | Administration on Aging | $85,000 | Small business innovative research program (90BI0003) |
| 2014-07-23 | National Institutes of Health | $1,200,000 | A mobile framework to measure ejection fraction by automated non-invasive analysis of cardiac signals (R44MD009556) |
| 2014-07-23 | National Institutes of Health | $463,150 | A mobile framework to measure ejection fraction by automated non-invasive analysi (R43MD009556) |
| 2014-01-01 | National Science Foundation | $150,000 | SBIR Phase I: Multi-dimensional cardiogram device for diagnosing valvular heart diseases (1345690) |
| 2013-10-01 | Department of Education | $415,000 | Small business innovation research (SBIR) program (H133S130071) |
| 2013-06-20 | Department of the Navy | $80,000 | Status report (N0002413P4019) |
| 2012-10-01 | Department of Education | $75,000 | Small business innovation research (SBIR) program (H133S120026) |
| 2011-09-15 | National Institutes of Health | $95,949 | Speech therapy robot (str) to assist in the administration of evidence based spee (R43LM011325) |
| 2011-06-30 | Departmental Offices | $749,956 | SBIR 9.2 Phase II - title: "acoustic source separation and localization" (IND11PC20163) |
| 2010-07-01 | National Science Foundation | $150,000 | SBIR Phase I: Affordable stutter treatment device to prevent relapse following therapy (1013462) |
| 2010-01-11 | Department of the Army | $98,816 | DARPA SBIR Phase I (W31P4Q10C0037) |
Who runs it, who owns it, where the money comes from and what to watch for, every claim linked to its source.
Order Full Report on Aventusoft L.l.cLook up Aventusoft L.l.c first. Finding the company and seeing how much is on record uses no credits.
Look up Aventusoft L.l.cWhere this comes from
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs set aside part of federal research budgets for small companies. Agencies award them in phases: Phase I tests whether an idea is feasible, Phase II funds development, and Phase III is follow-on work paid for outside the set-aside. STTR awards also require a research institution as a partner.
Every figure on this page is taken from the award's own federal record, linked beside it, as it stood when the page was built: the recipient, its address, the awarding agency and office, the amount obligated so far, the dates and the description. Phase and program are shown as the award's own description states them. The amount can grow later if the agency adds funding to the same award.